Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-21-071914
Filing Date
2021-05-25
Accepted
2021-05-25 17:27:49
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2039434-8_s1a.htm S-1/A 2591559
2 EXHIBIT 1.1 tm2039434d9_ex1-1.htm EX-1.1 186293
3 EXHIBIT 5.1 tm2039434d9_ex5-1.htm EX-5.1 6326
4 EXHIBIT 10.17 tm2039434d9_ex10-17.htm EX-10.17 8282
5 EXHIBIT 23.1 tm2039434d9_ex23-1.htm EX-23.1 2799
6 EXHIBIT 23.3 tm2039434d9_ex23-3.htm EX-23.3 3065
7 EXHIBIT 23.5 tm2039434d9_ex23-5.htm EX-23.5 3089
8 GRAPHIC lg_alzamendneuro-4clr.jpg GRAPHIC 47608
9 GRAPHIC tm2039434d8-cov_ifc4clr.jpg GRAPHIC 4227073
10 GRAPHIC tm2039434d8-pht_alzhei4clr.jpg GRAPHIC 368812
11 GRAPHIC tm2039434d8-tbl_develop4clr.jpg GRAPHIC 141774
12 GRAPHIC tm2039434d8-tbl_patents4clr.jpg GRAPHIC 164857
13 GRAPHIC tm2039434d9_ex5-1img001.jpg GRAPHIC 6837
14 GRAPHIC tm2039434d9_ex5-1img002.jpg GRAPHIC 4354
  Complete submission text file 0001104659-21-071914.txt   9634217
Mailing Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612
Business Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: S-1/A | Act: 33 | File No.: 333-255955 | Film No.: 21961815
SIC: 2834 Pharmaceutical Preparations